Proactive Investors - Run By Investors For Investors

Investors should run from Sports Direct, Peel Hunt reckons

Investors should run from Sports Direct, Peel Hunt reckons
Picture: Marco Prati / Shutterstock.com

Peel Hunt has just started coverage on Mike Ashley’s Sports Direct and it doesn’t make for pretty reading.

The broker said: “While the poor level of disclosure makes regional analysis almost impossible, it is clear that across the retail empire, like-for-like sales growth has been hard to come by; that is disappointing given that trainers and sportswear are such growth markets.”

It reckons a value-adding acquisition is required, and soon, but the rush could cause problems for management, especially with its most recent buy, Eybl in Austria, proving to be much harder work than anticipated.

The broker initiated coverage with a ‘sell’ rating, stating that “the risks outweigh the potential”.

Goldman Sachs upgraded Hikma Pharmaceuticals (LON:HIK) to ‘buy’ from ‘neutral’, and lifted its price target to 2,840p from 2,210p.

The drug maker has been in focus recently following its US$2.6bn acquisition of Roxane, a US generic drug firm, and Goldman is the latest finance group to turn positive in its outlook.

Elsewhere, as oil prices remain volatile BP (LON:BP.) was downgraded to ‘underperform’ from ‘neutral’ by Bank of America Merrill Lynch.

JP Morgan sees a 9% dent in Go-Ahead’s (LON:GOG) earnings due to a “spluttering” performance of its buses division.

“While the rail business came in ahead of expectations, the bus divisions were slightly behind, and worsening conditions with respect to roadworks and passenger numbers led to management delaying its £100m bus operating profit target,” analyst Jolyton Wellington said in a note.

The American bank highlighted that Go Ahead currently has a premium rating in its sector, as it repeated a ‘neutral’ recommendation and reduced its price target to 2,585p from 2,768p.

Royal Bank of Canada upgraded insurer Hiscox (LON:HSX) to ‘sector perform’ from ‘underperform’ and increased its price target to 645p from 607p.

In small caps, VSA Capital reckons Asiamet Resources’ (LON:ARS) chief exective topping up his stake is “a particularly positive sign”.

Tony Manini bought 3.5mln shares for £45,000 taking his stake to 2.9%.

Jamie_55a91591db06b.jpg


Register here to be notified of future HIK Company articles

No investment advice: The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use